Search Results 781-790 of 12636 for 🎙💯line:sammibaby💯🍓利曼集團🔶13歲可以减肥嗎？🚕澎湖县力曼傳銷🐥臺北市甩脂减肥有用🏘中坜区曼力國際🔐板桥区家用减肥器材哪個减肥好

1. A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Participation eligibility · Must have documented multiple myeloma and measurable disease · Must have received at least 1 prior line of therapy for multiple ...

2. Studying the Hedonic and Homeostatic Regulation of Food Intake using Functional MRI - Mayo Clinic

   About this study. The objectives of this study are to identify the unique individual neuro-hormonal footprint of volumetric, caloric, and hedonic ...

3. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

   This research trial studies genetic profiles in blood and tumor samples from patients with estrogen receptor positive and HER2 negative breast cancer that has ...

4. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   JCAR017 is a CAR-T therapy directed against CD19 (a cell surface protein on NHL cancer cells), meaning that a patient's own T-cells are collected from their ...

5. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

   No response to first-line therapy (primary refractory disease);; No response to second or greater lines of therapy; OR; Refractory after autologous stem cell ...

6. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   This phase II, single-arm study was designed to evaluate the effect of MPDL3280A treatment in patients with locally advanced or metastatic urothelial bladder ...

7. GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC - Mayo Clinic

   Patients with Stage III/IV NSCLC on first line treatment with anti-PD-1/PD-L1 (ICI) +/- chemotherapy for their current stage of disease and fits into one of ...

8. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of PANZYGA in pediatric patients with chronic Immune Thrombocytopenia (ITP). Participation ...

9. A Study of How the Regulation of Resting Blood Pressure is Altered in Menopausal Women - Mayo Clinic

   About this study. The purpose of this study is to investigate whether the autonomic support of blood pressure alters after menopause in women, ...

10. Sofosbuvir/GS-5816 Fixed-Dose Combination in Adults with Chronic HCV Infection and Child-Pugh Class B Cirrhosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...